Cargando…
Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review
The many internal and external factors that contribute to the pathophysiology of dry eye disease (DED) create a difficult milieu for its study and complicate its clinical diagnosis and treatment. The controlled adverse environment (CAE(®)) model has been developed to minimize the variability that ar...
Autores principales: | Ousler, George W., Rimmer, David, Smith, Lisa M., Abelson, Mark B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693827/ https://www.ncbi.nlm.nih.gov/pubmed/28956287 http://dx.doi.org/10.1007/s40123-017-0110-x |
Ejemplares similares
-
A single-center study evaluating the effect of the controlled adverse environment (CAE(SM)) model on tear film stability
por: Abelson, Richard, et al.
Publicado: (2012) -
Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model
por: Sosne, Gabriel, et al.
Publicado: (2015) -
Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy
por: Gomes, Paulo J, et al.
Publicado: (2013) -
CAE advantage
por: Kingsbury, Roy, 1940-
Publicado: (1992) -
The Cambridge CAE course /
por: Spratt, Mary